164 related articles for article (PubMed ID: 30878131)
21. Distinct power of bone marrow microRNA signatures and tumor suppressor genes for early detection of acute leukemia.
Memari F; Tavakolpour V; Mohajeri N; Poopak B; Fallah P; Alizadeh E; Kouhkan F; Zarghami N
Clin Transl Oncol; 2022 Jul; 24(7):1372-1380. PubMed ID: 35247197
[TBL] [Abstract][Full Text] [Related]
22. Up-regulated miR-155 is associated with poor prognosis in childhood acute lymphoblastic leukemia and promotes cell proliferation targeting ZNF238.
Liang C; Li Y; Wang LN; Zhang XL; Luo JS; Peng CJ; Tang WY; Huang LB; Tang YL; Luo XQ
Hematology; 2021 Dec; 26(1):16-25. PubMed ID: 33357126
[TBL] [Abstract][Full Text] [Related]
23. Expression pattern of
Chu X; Wu D; Zhang C; Hu S
Scand J Clin Lab Invest; 2023 Jul; 83(4):207-211. PubMed ID: 37093849
[TBL] [Abstract][Full Text] [Related]
24. miRNA expression profiles in chronic lymphocytic and acute lymphocytic leukemia.
Zanette DL; Rivadavia F; Molfetta GA; Barbuzano FG; Proto-Siqueira R; Silva WA; Falcão RP; Zago MA
Braz J Med Biol Res; 2007 Nov; 40(11):1435-40. PubMed ID: 17934639
[TBL] [Abstract][Full Text] [Related]
25. Value of serum miR-922 and miR-506 expression levels in the diagnosis and prognostic assessment of childhood acute lymphoblastic leukemia.
Zhu YY; Wu RN; Li X; Chen XB
Zhongguo Dang Dai Er Ke Za Zhi; 2021 Oct; 23(10):1021-1026. PubMed ID: 34719417
[TBL] [Abstract][Full Text] [Related]
26. Integrating MicroRNA Expression Profiling Studies to Systematically Evaluate the Diagnostic Value of MicroRNAs in Pancreatic Cancer and Validate Their Prognostic Significance with the Cancer Genome Atlas Data.
Zhang Z; Pan B; Lv S; Ji Z; Wu Q; Lang R; He Q; Zhao X
Cell Physiol Biochem; 2018; 49(2):678-695. PubMed ID: 30165365
[TBL] [Abstract][Full Text] [Related]
27. [microRNA expression in childhood acute granulocytic leukemia and its subtypes].
Luo XQ; Xu L; Ke ZY; Huang LB; Zhang XL; Zhang LD
Zhonghua Zhong Liu Za Zhi; 2011 Nov; 33(11):831-5. PubMed ID: 22335948
[TBL] [Abstract][Full Text] [Related]
28. Clinical utility of miR-143/miR-182 levels in prognosis and risk stratification specificity of BFM-treated childhood acute lymphoblastic leukemia.
Piatopoulou D; Avgeris M; Drakaki I; Marmarinos A; Xagorari M; Baka M; Pourtsidis A; Kossiva L; Gourgiotis D; Scorilas A
Ann Hematol; 2018 Jul; 97(7):1169-1182. PubMed ID: 29556721
[TBL] [Abstract][Full Text] [Related]
29. MicroRNA-181a and its target Smad 7 as potential biomarkers for tracking child acute lymphoblastic leukemia.
Nabhan M; Louka ML; Khairy E; Tash F; Ali-Labib R; El-Habashy S
Gene; 2017 Sep; 628():253-258. PubMed ID: 28732737
[TBL] [Abstract][Full Text] [Related]
30. Hsa-miR-196a2 polymorphism increases the risk of acute lymphoblastic leukemia in Chinese children.
Tong N; Xu B; Shi D; Du M; Li X; Sheng X; Wang M; Chu H; Fang Y; Li J; Wu D; Zhang Z
Mutat Res; 2014 Jan; 759():16-21. PubMed ID: 24291415
[TBL] [Abstract][Full Text] [Related]
31. Role of microRNA dysregulation in childhood acute leukemias: Diagnostics, monitoring and therapeutics: A comprehensive review.
Szczepanek J
World J Clin Oncol; 2020 Jun; 11(6):348-369. PubMed ID: 32855905
[TBL] [Abstract][Full Text] [Related]
32. The diagnostic role of microRNA-34a in breast cancer: a systematic review and meta-analysis.
Imani S; Zhang X; Hosseinifard H; Fu S; Fu J
Oncotarget; 2017 Apr; 8(14):23177-23187. PubMed ID: 28423566
[TBL] [Abstract][Full Text] [Related]
33. Differential microRNA expression in childhood B-cell precursor acute lymphoblastic leukemia.
Ju X; Li D; Shi Q; Hou H; Sun N; Shen B
Pediatr Hematol Oncol; 2009 Jan; 26(1):1-10. PubMed ID: 19206004
[TBL] [Abstract][Full Text] [Related]
34. Diagnostic and prognostic value of circulating miR-21 for cancer: a systematic review and meta-analysis.
Wang Y; Gao X; Wei F; Zhang X; Yu J; Zhao H; Sun Q; Yan F; Yan C; Li H; Ren X
Gene; 2014 Jan; 533(1):389-97. PubMed ID: 24076132
[TBL] [Abstract][Full Text] [Related]
35. Upregulation of microRNA-21 is a poor prognostic marker in patients with childhood B cell acute lymphoblastic leukemia.
Labib HA; Elantouny NG; Ibrahim NF; Alnagar AA
Hematology; 2017 Aug; 22(7):392-397. PubMed ID: 28253825
[TBL] [Abstract][Full Text] [Related]
36. Circulating miR-146a expression as a non-invasive predictive biomarker for acute lymphoblastic leukemia.
Shahid S; Shahid W; Shaheen J; Akhtar MW; Sadaf S
Sci Rep; 2021 Nov; 11(1):22783. PubMed ID: 34815474
[TBL] [Abstract][Full Text] [Related]
37. The miR-1206 microRNA variant is associated with methotrexate-induced oral mucositis in pediatric acute lymphoblastic leukemia.
Gutierrez-Camino A; Oosterom N; den Hoed MAH; Lopez-Lopez E; Martin-Guerrero I; Pluijm SMF; Pieters R; de Jonge R; Tissing WJE; Heil SG; García-Orad A; van den Heuvel-Eibrink MM
Pharmacogenet Genomics; 2017 Aug; 27(8):303-306. PubMed ID: 28628559
[TBL] [Abstract][Full Text] [Related]
38. Prognostic miRNA classifiers in t cell acute lymphoblastic leukemia: Study protocol for a systematic review and meta-analysis of observational clinical studies.
Sabarimurugan S; Madurantakam Royam M; Kumarasamy C; Kodiveri Muthukaliannan G; Samiappan S; Jayaraj R
Medicine (Baltimore); 2019 Mar; 98(9):e14569. PubMed ID: 30817574
[TBL] [Abstract][Full Text] [Related]
39. Prognostic value of miR-16 expression in childhood acute lymphoblastic leukemia relationships to normal and malignant lymphocyte proliferation.
Kaddar T; Chien WW; Bertrand Y; Pages MP; Rouault JP; Salles G; Ffrench M; Magaud JP
Leuk Res; 2009 Sep; 33(9):1217-23. PubMed ID: 19195700
[TBL] [Abstract][Full Text] [Related]
40. Prospective evaluation of whole genome microRNA expression profiling in childhood acute lymphoblastic leukemia.
Duyu M; Durmaz B; Gunduz C; Vergin C; Yilmaz Karapinar D; Aksoylar S; Kavakli K; Cetingul N; Irken G; Yaman Y; Ozkinay F; Cogulu O
Biomed Res Int; 2014; 2014():967585. PubMed ID: 24955371
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]